Recently adopted names for antitumoral compounds (March 2012) - Noms d’antitumoraux adoptés récemment (mars 2012)

Name	Code name	Type	Target(s)
gemcitabine elaidate	CP-4126	Nucleotide analogue	Ribonucleotide reductase
golvatinib	E7050	Synthetic small molecule	MET
golvatinib tartrate	ER-396901-08	Synthetic small molecule	MET
ocaratuzumab	AME-133v, LY2469298	Humanized monoclonal antibody	CD20
quisinostat hydrochloride	JNJ-26481585; JNJ-26481585-AAC	Synthetic small molecule	HDAC

More on gemcitabine elaidate:

http://www.ncbi.nlm.nih.gov/pubmed/20066470

More on golvatinib:

http://www.ncbi.nlm.nih.gov/pubmed/22317763

More on ocaratuzumab:

http://www.ncbi.nlm.nih.gov/pubmed/22223529

More on quisinostat hydrochloride:

http://clincancerres.aacrjournals.org/content/15/22/6841.full.pdf+html